IP Library › Granted Patent US 7,956,175
Granted Patent B2
US 7,956,175 · App. 11/683,280 · Granted Jun 7, 2011

Compositions for use in identification of bacteria

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,956,175
App. No.
11/683,280
Granted
Jun 7, 2011
Kind
B2
Abstract

The present invention provides compositions, kits and methods for rapid identification and quantification of bacteria by molecular mass and base composition analysis.

Claims (15)

1. An oligonucleotide primer pair comprising a forward primer and a reverse primer, wherein said forward primer comprises the sequence of SEQ ID NO:318, and wherein said reverse primer comprises a sequence 95% identical to SEQ ID NO:1300.

2. The oligonucleotide primer pair of claim 1 wherein said forward primer is SEQ ID NO: 318.

3. The oligonucleotide primer pair of claim 1 , wherein said reverse primer comprises the sequence of SEQ ID NO:1300.

4. The oligonucleotide primer pair of claim 1 wherein said reverse primer is SEQ ID NO: 1300.

5. The oligonucleotide primer pair of claim 1 wherein at least one of said forward primer and said reverse primer comprises at least one modified nucleobase.

6. The oligonucleotide primer pair of claim 5 wherein at least one of said at least one modified nucleobase is a mass modified nucleobase.

7. The oligonucleotide primer pair of claim 6 wherein said mass modified nucleobase is 5-Iodo-C.

8. The composition of claim 6 wherein said mass modified nucleobase comprises a molecular mass modifying tag.

9. The oligonucleotide primer pair of claim 5 wherein at least one of said at least one modified nucleobase is a universal nucleobase.

10. The oligonucleotide primer pair of claim 9 wherein said universal nucleobase is inosine.

11. The oligonucleotide primer pair of claim 1 , wherein at least one of said forward primer and said reverse primer comprises a T residue at its 5′ end.

12. A kit for identifying, determining one or more characteristics of, or detecting a Staphylococcus aureus bioagent comprising the oligonucleotide primer pair of claim 1 and at least one additional primer pair designed to hybridize to a Staphylococcus aureus gene encoding arcC, aroE, gmk, pta, yqi, or a combination thereof.

13. The kit of claim 12 further comprising at least one other additional primer pair designed to hybridize to a Staphylococcus aureus gene encoding mecA, mecR1, pvluk, or a combination thereof.

14. The kit of claim 12 wherein said at least one additional primer pair comprises SEQ ID NOs: 437:1232, SEQ ID NOs: 590:891, SEQ ID NOs: 474:869, SEQ ID NOs: 268:1284, SEQ ID NOs: 418:1301, SEQ ID NOs: 440:1076, SEQ ID NOs: 219:1013, or a combination thereof.

15. The kit of claim 12 wherein each primer of said at least one additional primer pair has at least 70% sequence identity with one of SEQ ID NOs: 437, 1232, 590, 891, 474, 869, 268, 1284, 418, 1301, 318, 1300, 440, 1076, 219 and 1013.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2007
From: ISIS PHARMACEUTICALS, INC.
To: IBIS BIOSCIENCES, INC.
Reel/Frame 019691/0776 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2007
From: SAMPATH, RANGARAJAN; HALL, THOMAS A.; ECKER, DAVID J.; BLYN, LAWRENCE
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 019315/0991 →